Healthcare
Monday, December 5, 2016
BRIEF-Alnylam presents updated results from phase 1/2 study of ALN-CC5 in patients with paroxysmal nocturnal hemoglobinuria
* Alnylam presents updated results from phase 1/2 study of
aln-cc5 in patients with paroxysmal nocturnal hemoglobinuria
(pnh)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment